Merck
$126.14-1.36Valor de mercado
$358.4B
Posição global
#35
Máxima histórica
$386.0B
2026-08-25
Crescimento total
+0%
desde 2026
Market Cap Context
- Larger than 90% of the 367 companies we track (globally).
- Equivalent to 1.2% of United States's GDP (2025 data).
- Just above: #34 Procter & Gamble (P&G) ($373.2B)
- Just below: #36 Bank of America ($353.6B)
- Best year: 1995 (+77%). Worst year: 2008 (-46%).
Merck Financial Breakdown (FY 2025)
Source: Yahoo Finance — MRK annual filings (2025) →$65.0B revenue · $22.1B operating income · $18.3B net income
- ●Operating margin: 34.0% on $65.0B in revenue.
- ●R&D is 24.3% of revenue ($15.8B).
- ●Net income margin: 28.1% — $18.3B in profit.
- ●Free cash flow: $12.4B (19.0% of revenue).
Cost / Operating Expenses
Total operating expenses $42.9B
Total
$42.9B
Capital Expenditures
$4.1B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$12.4B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
Fundamentals (TTM)
Data: Financial Modeling PrepP/E
—
EPS
—
Net margin
—
ROE
—
Dividend yield
—
Debt / Equity
—
Sobre a Merck
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue.
Histórico de valor de mercado da Merck (2026–2026)
Merck vs Sector Peers by Market Cap
Comparar Merck
Histórico de classificação
| Ano | Valor de mercado | Posição | Variação anual |
|---|---|---|---|
| 2026 | $358.4B | #35(↑14) | +40.1% |
| 2025 | $255.9B | #49(↓13) | +9.7% |
| 2024 | $233.2B | #36(↓3) | -6.3% |
| 2023 | $248.9B | #33(↓5) | +0.9% |
| 2022 | $246.6B | #28(↑27) | +49.8% |
| 2021 | $164.6B | #55(↓12) | +1.6% |
| 2020 | $162.0B | #43(↓12) | -7.3% |
| 2019 | $174.8B | #31(↓4) | +22.3% |
| 2018 | $142.9B | #27(↑19) | +40.2% |
| 2017 | $102.0B | #46(↓13) | -1.6% |
| 2016 | $103.6B | #33 | +15.2% |
| 2015 | $89.9B | #33(↓3) | -4.0% |
| 2014 | $93.7B | #30(↑5) | +17.1% |
| 2013 | $80.0B | #35(↓1) | +26.9% |
| 2012 | $63.0B | #34(↓2) | +13.4% |
| 2011 | $55.6B | #32(↑5) | +9.4% |
| 2010 | $50.8B | #37(↓6) | +2.9% |
| 2009 | $49.4B | #31(↓2) | +27.2% |
| 2008 | $38.8B | #29(↓5) | -45.8% |
| 2007 | $71.6B | #24(↑6) | +37.6% |
| 2006 | $52.0B | #30(↑10) | +41.5% |
| 2005 | $36.8B | #40(↓7) | +5.5% |
| 2004 | $34.8B | #33(↓16) | -28.1% |
| 2003 | $48.5B | #17(↓6) | -11.4% |
| 2002 | $54.7B | #11(↑3) | -1.3% |
| 2001 | $55.5B | #14(↓5) | -36.1% |
| 2000 | $86.7B | #9(↑6) | +41.7% |
| 1999 | $61.2B | #15(↓6) | -7.5% |
| 1998 | $66.2B | #9 | +41.5% |
| 1997 | $46.8B | #9 | +35.7% |
| 1996 | $34.5B | #9(↓1) | +24.0% |
| 1995 | $27.8B | #8(↑6) | +77.1% |
| 1994 | $15.7B | #14 |
Outras empresas do setor Saúde
Perguntas frequentes
What is Merck & Co., Inc.'s market cap?
Merck & Co., Inc. (MRK) has a market capitalization of $358.4B, making it the #35 largest company in the world by market cap.
What was Merck & Co., Inc.'s highest market cap?
Merck & Co., Inc.'s all-time high market cap was $386.0B, reached in 2026-08-25. Its highest rank was #35 in 2026.
What sector is Merck & Co., Inc. in?
Merck & Co., Inc. is in the Healthcare sector, specifically the Drug Manufacturers - General industry. It is based in United States.
How has Merck & Co., Inc.'s market cap changed over time?
Merck & Co., Inc. has been tracked since 2026. Its market cap has grown by 0% from $358.4B in 2026 to $358.4B today.